| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |